Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Herbert Kvaternik"'
Autor:
Elisabeth Plhak, Christopher Pichler, Björn Dittmann-Schnabel, Edith Gößnitzer, Reingard M. Aigner, Susanne Stanzel, Herbert Kvaternik
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1138 (2023)
[68Ga]Ga-FAPI-46 is a radiolabelled fibroblast activation protein inhibitor that selectively binds to fibroblast activation protein (FAP), which is overexpressed by cancer-associated fibroblasts (CAFs) in the tumour microenvironment. In recent years,
Externí odkaz:
https://doaj.org/article/2e3619284f614597914cfc14a6869b6d
Publikováno v:
Molecules, Vol 28, Iss 2, p 577 (2023)
Many radioactive PSMA inhibitory substances have already been developed for PET diagnostics and therapy of prostate cancer. Because PET radionuclides and instrumentation may not be available, technetium-99 m labelled tracers can be considered as a di
Externí odkaz:
https://doaj.org/article/671e7cd51cb24f85aa1dffaac8f4d2d1
Autor:
Anton Amadeus Hörmann, Elisabeth Plhak, Maximilian Klingler, Christine Rangger, Joachim Pfister, Gert Schwach, Herbert Kvaternik, Elisabeth von Guggenberg
Publikováno v:
Molecules, Vol 27, Iss 6, p 2034 (2022)
The new minigastrin analog DOTA-MGS8 targeting the cholecystokinin-2 receptor (CCK2R) used in this study displays the combination of two site-specific modifications within the C-terminal receptor binding sequence together with an additional N-termina
Externí odkaz:
https://doaj.org/article/9a29287298c147499a41e800a70a5f70
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 96 (2022)
Dopaminergic transporter (DAT) imaging with single photon emission computed tomography (SPECT) is used to diagnose Parkinson’s disease and to differentiate it from other neurodegenerative disorders without presynaptic dopaminergic dysfunction. The
Externí odkaz:
https://doaj.org/article/bdbaa1920262445d85dc3eb38c896264
Autor:
Anton Amadeus, Hörmann, Elisabeth, Plhak, Maximilian, Klingler, Christine, Rangger, Joachim, Pfister, Gert, Schwach, Herbert, Kvaternik, Elisabeth, von Guggenberg
Publikováno v:
Molecules (Basel, Switzerland). 27(6)
The new minigastrin analog DOTA-MGS8 targeting the cholecystokinin-2 receptor (CCK2R) used in this study displays the combination of two site-specific modifications within the C-terminal receptor binding sequence together with an additional N-termina
Publikováno v:
Journal of Nuclear Medicine Technology. 48:168-173
The phenomenon of adsorption of several 99mTc-radiopharmaceuticals onto disposable syringes is common knowledge and can reach a level of up to 50%, with the result being inadequate dosing. The resulting underdosing has a substantial influence on the
Autor:
Herbert Kvaternik, Roman Kulnik, Reingard Aigner, Birgit Pernthaler, Spela Salamon, Christian Gstettner
Publikováno v:
Clinical Nuclear Medicine. 44:e566-e573
One of the major challenges for all imaging modalities is accurate detection of prostate cancer (PCa) recurrence. Beyond the established Ga-PSMA, a novel promising PET tracer in PCa imaging is F-fluciclovine. For evaluating the advantages and disadva
Autor:
Reingard Aigner, Birgit Pernthaler, Herbert Kvaternik, Tina Nazerani Hooshmand, Jasminka Igrec
Publikováno v:
Clinical nuclear medicine. 46(4)
Prostate cancer (PC) is one of the most common cancers affecting men worldwide, with a high recurrence rate after therapy. 68Ga-PSMA-11 and 18F-fluciclovine are PET imaging tracers for the detection of recurrence sites in PC patients. 68Ga-PSMA-11 is
Publikováno v:
Nuclear Medicine and Biology. :S59-S60
Publikováno v:
Nuclear Medicine and Biology. :S100